Dr. Robert Vries
Chief Executive Officer
First organoid generated from mouse intestine
First human organoid developed from intestinal epithelium
Hubrecht Organoid Technology Foundation was established to upscale and commercialize organoid technology
First cystic fibrosis patient treated based on organoid data
HIT-CF validation trial launched
First oncology clinical candidate entirely developed using organoid screening approved for clinical trials
Expansion of lab facilities
Hubrecht Organoid Technology becomes HUB Organoids B.V.
HUB Organoids is led by a proficient team that has extensive expertise in scientific, commercial, and technological areas within the life sciences field. Their diverse backgrounds and skillset collectively embody our company’s values, culture, and commitment to advancing patient-relevant therapeutic solutions to the world.
News & Insights
Events